BeOne Medicines (BEIGF) EPS (Weighted Average and Diluted) Growth (3y) (2021 - 2026)
BeOne Medicines (BEIGF) EPS (Weighted Average and Diluted) Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
59.54% |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
22,777.33% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
1,857.10% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
41.33% |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
14.33% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
37.10% |
| Date | Value |
|---|
| Mar 31, 2026 |
37.10% |
| Dec 31, 2025 |
28.49% |
| Sep 30, 2025 |
29.96% |
| Jun 30, 2025 |
28.92% |
| Dec 31, 2024 |
39.22% |
| Sep 30, 2024 |
37.00% |
| Jun 30, 2024 |
39.18% |
| Mar 31, 2024 |
-79.67% |
| Mar 31, 2023 |
10.28% |
| Sep 30, 2021 |
-23.74% |
